By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Wealth Beat NewsWealth Beat News
  • Home
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Notification Show More
Aa
Wealth Beat NewsWealth Beat News
Aa
  • News
  • Finance
  • Investing
  • Banks
  • Mortgage
  • Loans
  • Credit Cards
  • Small Business
  • Dept Management
Follow US
Wealth Beat News > News > SCHM ETF: Downward Earnings And Sales Revision Will Cause More Downside
News

SCHM ETF: Downward Earnings And Sales Revision Will Cause More Downside

News
Last updated: 2023/05/10 at 10:51 AM
By News
Share
7 Min Read
SHARE

Contents
ETF OverviewIntroductionFund AnalysisInvestor Takeaway

ETF Overview

Mid-cap stocks only represent about 10% of the total U.S. market. As a result, it is often overlooked. Should investors be owning mid-cap stocks now? In this article, we will analyze Schwab U.S. Mid-Cap ETF (NYSEARCA:SCHM) and provide our insights and suggestions.

Introduction

SCHM owns 500 mid-cap stocks in the United States. Although mid-cap stocks have experienced prices decline since 2022, this is likely not the end of the tunnel yet. Given that a recession is likely to arrive in the second half of 2023, many mid-cap stocks may still experience a significant decline in forward earnings and revenues. Therefore, SCHM’s fund price will likely continue to decline as the economy eventually enters a recession. At this moment, we think it is still premature to initiate a position. Investors should wait on the sidelines instead.

Chart

YCharts

Fund Analysis

SCHM has stabilized after a dramatic decline last year

SCHM had an abysmal year in 2022 due to the Federal Reserve’s aggressive monetary tightening policy to combat inflation. The fund has delivered a peak to trough loss of nearly 25% from the beginning of 2022 to the low in October 2022. Fortunately, its fund price appears to have stabilized in 2023 and has recovered some of the losses. Still, the fund has delivered a loss of about 17.13% since January 2022.

Chart

YCharts

SCHM’s valuation has experienced significant contraction.

Below is a chart that shows the forward P/E ratios of the S&P 400 Mid-Cap and Russell Mid-Cap indexes. Stocks in these two indexes should provide a good representation of U.S. mid-cap stocks. Therefore, it should at least give us some sense of whether mid-cap stocks are overvalued or undervalued. As can be seen from the chart below, both two indexes have experienced significant valuation contractions since reaching their highs in 2020. As can be seen from the chart, the S&P 400 Mid-Cap’s valuation of 13.3x is now towards the low end of the historical range since 1999. In contrast, Russell Mid-Cap’s valuation of 16.5x is in the middle of its historical range.

Chart Description automatically generated

Yardeni Research

What if there is going to be a recession coming up?

While the U.S. economy appears to be resilient with a strong job market, we believe there is a strong likelihood a recession will eventually be triggered. This is because persistently high inflation may force the Federal Reserve to keep the rate elevated for longer. Although the chance is slim, the Federal Reserve may even move the rate a lot higher in order to tame inflation. Given that the impact of the rate hike typically takes about 6 months to 12 months to ripple through the economy, we may soon see a decelerating economy. This should help bring down the inflation but also cause a recession.

Below is the chart that shows the forward earnings of the S&P 400 Mid-Cap index in the past two decades. As can be seen from the chart, the index’s forward earnings have been revised significantly downward in the past two recessions. Although we are already seeing some earnings revisions lately, we believe there is still more room to be revised downward in the upcoming recession.

Chart Description automatically generated

Yardeni Research

Below is another chart that shows the forward revenue of the S&P 400 Mid-Cap index in the past 20 years. As can be seen from the chart below, in the past two recessions (2008/2009, and 2020), forward revenues of mid-cap stocks in the S&P 400 index experienced revenue declines. This decline happened not before the recession but typically during it. Hence, it explains why that we have yet to see a forward revenue decline.

Chart, line chart Description automatically generated

Yardeni Research

Both charts tell us that there were significant earnings and sales revision during the past two recessions. Since we are anticipating a recession coming very soon, we do expect forward earnings and sales to be revised downward. This will inevitably impact the prices of mid-cap stocks negatively.

SCHM can decline significantly in an economic recession

We know that mid-cap stocks will experience significant earnings and revenue revisions. Here, we will look at how SCHM’s fund price will be impacted in a recession. As can be seen from the chart below, SCHM endured a loss of nearly 45% during the outbreak of 2020 pandemic. Since SCHM’s inception date was in 2011, we do not have the historical chart during the 2008/2009 recession. However, we do know that the S&P 400 Mid-Cap index declined by nearly 60% during the Great Recession in 2008/2009. Depending on the severity of the upcoming recession, we may likely see a decline of at least 30% if it is a mild recession and a decline more than 50% if it is a severe recession. Hence, there may be more room for SCHM to decline.

Chart

YCharts

Investor Takeaway

As we have analyzed in our article, we do not have a positive view of SCHM in the next 6 months due to the possibility of a recession. The likelihood of a further decline in SCHM’s fund price is very high. Therefore, we think it may be better to stay on the sidelines.

Additional Disclosure: This is not financial advice and that all financial investments carry risks. Investors are expected to seek financial advice from professionals before making any investment.

Read the full article here

News May 10, 2023 May 10, 2023
Share this Article
Facebook Twitter Copy Link Print
Leave a comment Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Fast Four Quiz: Precision Medicine in Cancer

How much do you know about precision medicine in cancer? Test your knowledge with this quick quiz.
Get Started
Excelerate Energy: Nearby Best Energy-Source Cap-Gain Prospect (NYSE:EE)

The primary focus of this article is Excelerate Energy, Inc. (NYSE:EE). Investment…

Penske Is Steady, But The Road Ahead May Be Bumpy (NYSE:PAG)

Investing Thesis On Wednesday, Penske Automotive Group (NYSE:PAG) released a superficially encouraging…

Top Financial – No, Stop It, This Is Silly (NASDAQ:TOP)

TOP Financial Moves, yes, but why? TOP Financial (NASDAQ:TOP) was quite the…

You Might Also Like

News

Charting Public Debt With Peder Beck-Friis

By News
News

TechnipFMC Stock: More Than Just Momentum (NYSE:FTI)

By News
News

Politics And The Markets 06/19/25

By News
News

Smith & Wesson Brands, Inc. (SWBI) Q4 2025 Earnings Call Transcript

By News
Facebook Twitter Pinterest Youtube Instagram
Company
  • Privacy Policy
  • Terms & Conditions
  • Contact US
More Info
  • Newsletter
  • Finance
  • Investing
  • Small Business
  • Dept Management

Sign Up For Free

Subscribe to our newsletter and don't miss out on our programs, webinars and trainings.

I have read and agree to the terms & conditions

Join Community

2025 © wealthbeatnews.com. All Rights Reserved.

Join Us!

Subscribe to our newsletter and never miss our latest news, podcasts etc.

I have read and agree to the terms & conditions
Zero spam, Unsubscribe at any time.
Welcome Back!

Sign in to your account

Lost your password?